Valuation: Cannabis Bioscience International Holdings, Inc.

Market Cap 23.68L 20.74L 19.26L 17.7L 33.35L 23Cr 33.84L 2.29Cr 89.79L 11Cr 88.88L 86.96L 39Cr P/E 2024
-9.52x
P/E 2025 -11.8x
Enterprise Value 33.68L 29.51L 27.4L 25.17L 47.44L 32Cr 48.14L 3.26Cr 1.28Cr 16Cr 1.26Cr 1.24Cr 55Cr EV / Sales 2024
28.9x
EV / Sales 2025 25.6x
Free-Float
41.59%
Yield 2024 *
-
Yield 2025 -
15/07 Cannabis Bioscience International Holdings Receives Texas License for Consumable Hemp Products CI
17/04 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 CI
20/02 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 CI
23/25/23 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 CI
06/25/06 Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors CI
23/25/23 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 CI
22/25/22 Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
22/25/22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025 CI
22/25/22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 CI
06/25/06 Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products CI
27/24/27 Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding CI
27/24/27 Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024 CI
25/24/25 Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip CI
1 week-50.00%
Current month-66.67%
1 month-66.67%
3 months-75.00%
6 months-80.00%
Current year-80.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0.01
10 years 0
Extreme 0
0.27
Manager TitleAgeSince
Chief Executive Officer 70 19/12/2019
Treasurer 61 06/05/2024
Corporate Secretary 66 19/12/2019
Director TitleAgeSince
Director/Board Member 70 19/12/2019
Director/Board Member 66 19/12/2019
Director/Board Member 61 06/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-50.00%-75.00%-80.00% 12.06L
+1.85%-4.83%-4.07%+12.75% 4.61TCr
-0.14%-0.76%+378.26%+583.71% 3.89TCr
+0.39%+2.79%+8.23%+61.99% 3.56TCr
-1.54%-4.01%+5.95%-13.03% 3.31TCr
-0.87%-3.19%-1.27%+29.16% 2.64TCr
-1.28%-6.20% - - 1.66TCr
-0.67%-0.21%+10.55%+115.31% 1.51TCr
-4.96%-3.48%+5.87%+9.61% 1.41TCr
+0.40%-2.79%+3.58%-31.98% 1.28TCr
Average -0.68%-7.03%+36.90%+76.39% 2.39TCr
Weighted average by Cap. -0.32%-2.60%+68.79%+122.98%

Financials

2024 2025
Net sales 2L 2L 2L 2L 4L 2.4Cr 4L 24.11L 9L 1.17Cr 9L 9L 4.06Cr 3L 3L 2L 2L 4L 2.92Cr 4L 29.36L 11.49L 1.43Cr 11.38L 11.13L 4.94Cr
Net income -7L -6L -5L -5L -9L -6.29Cr -9L -63.12L -24.7L -3.08Cr -24.45L -23.92L -11Cr -5L -5L -4L -4L -8L -5.3Cr -8L -53.18L -20.82L -2.59Cr -20.6L -20.16L -8.95Cr
Net Debt 9L 8L 8L 7L 13.23L 9.06Cr 13.42L 91.02L 35.63L 4.44Cr 35.26L 34.5L 15Cr 10L 9L 8L 7L 14.09L 9.65Cr 14.3L 96.94L 37.94L 4.72Cr 37.55L 36.75L 16Cr
Logo Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.
Employees
2
Date Price Change Volume
22/26/22 $0.000100 0.00% 15,33,552
21/26/21 $0.000100 -50.00% 8,00,10,100
20/26/20 $0.000200 0.00% 8,00,30,564
17/26/17 $0.000200 0.00% 10,150
16/26/16 $0.000200 0.00% 15,00,050
  1. Stock Market
  2. Stocks
  3. CBIH Stock